MicroRNA-155 may affect allograft survival by regulating the expression of suppressor of cytokine signaling 1

Medical Hypotheses

Volumn 77, Issue 4, 2011, Pages 682-684

  Zhang, Maomao ^a   Zhang, Qi ^a   Liu, Fang ^a   Yin, Li ^a   Yu, Bo ^a   Wu, Jian ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 155; SUPPRESSOR OF CYTOKINE SIGNALING 1; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ARTICLE; B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; DENDRITIC CELL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPOTHESIS; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; REGULATORY T LYMPHOCYTE; RNA SYNTHESIS; T LYMPHOCYTE; UPREGULATION;

GRAFT SURVIVAL; HUMANS; MICRORNAS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 80052622587     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.07.016     Document Type: Article

References (53)

1. He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004, 5:522-531.
2. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
3. Lindsay M.A. MicroRNAs and the immune response. Trends Immunol 2008, 29:343-351.
4. Jin P., Han T.H., Ren J., et al. Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies. J Transl Med 2010, 8:4.
5. Ceppi M., Pereira P.M., Dunand-Sauthier I., et al. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci USA 2009, 106:2735-2740.
6. Martinez-Nunez R.T., Louafi F., Friedmann P.S., Sanchez-Elsner T. MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN). J Biol Chem 2009, 284:16334-16342.
7. Cervigne N.K., Reis P.P., Machado J., et al. Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet 2009, 18:4818-4829.
8. Cremer T.J., Ravneberg D.H., Clay C.D., et al. MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation, enhanced pro-inflammatory cytokine response. PLoS One 2009, 4:e8508.
9. O'Connell R.M., Rao D.S., Chaudhuri A.A., et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 2008, 205:585-594.
10. Rodriguez A., Vigorito E., Clare S., et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007, 316:608-611.
11. Gantier M.P., Sadler A.J., Williams B.R. Fine-tuning of the innate immune response by microRNAs. Immunol Cell Biol 2007, 85:458-462.
12. Tili E., Michaille J.J., Calin G.A. Expression and function of micro-RNAs in immune cells during normal or disease state. Int J Med Sci 2008, 5:73-79.
13. Pipkin M.E., Monticelli S. Genomics and the immune system. Immunology 2008, 124:23-32.
14. Lodish H.F., Zhou B., Liu G., Chen C.Z. Micromanagement of the immune system by microRNAs. Nat Rev Immunol 2008, 8:120-130.
15. Marine J.C., Topham D.J., McKay C., et al. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 1999, 98:609-616.
16. Alexander W.S., Starr R., Fenner J.E., et al. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 1999, 98:597-608.
17. Naka T., Tsutsui H., Fujimoto M., et al. SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo. Immunity 2001, 14:535-545.
18. Nakagawa R., Naka T., Tsutsui H., et al. SOCS-1 participates in negative regulation of LPS responses. Immunity 2002, 17:677-687.
19. Kinjyo I., Hanada T., Inagaki-Ohara K., et al. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 2002, 17:583-591.
20. Dimitriou I.D., Clemenza L., Scotter A.J., Chen G., Guerra F.M., Rottapel R. Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol Rev 2008, 224:265-283.
21. Egan P.J., Lawlor K.E., Alexander W.S., Wicks I.P. Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. J Clin Invest 2003, 111:915-924.
22. Ritchie D.S., Hermans I.F., Lumsden J.M., et al. Dendritic cell elimination as an assay of cytotoxic T lymphocyte activity in vivo. J Immunol Methods 2000, 246:109-117.
23. Hanada T., Tanaka K., Matsumura Y., et al. Induction of hyper Th1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene. J Immunol 2005, 174:4325-4332.
24. Fu H., Song S., Liu F., et al. Dendritic cells transduced with SOCS1 gene exhibit regulatory DC properties and prolong allograft survival. Cell Mol Immunol 2009, 6:87-95.
25. Hanada T., Yoshida H., Kato S., et al. Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity. Immunity 2003, 19:437-450.
26. Lu L.F., Thai T.H., Calado D.P., et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 2009, 30:80-91.
27. Jiang S., Zhang H.W., Lu M.H., et al. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 2010, 70:3119-3127.
28. Valencia-Sanchez M.A., Liu J., Hannon G.J., Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006, 20:515-524.
29. Harris A., Krams S.M., Martinez O.M. MicroRNAs as immune regulators: implications for transplantation. Am J Transplant 2010, 10:713-719.
30. Volinia S., Calin G.A., Liu C.G., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006, 103:2257-2261.
31. Costinean S., Zanesi N., Pekarsky Y., et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci USA 2006, 103:7024-7029.
32. Kanwar J.R., Mahidhara G., Kanwar R.K. MicroRNA in human cancer and chronic inflammatory diseases. Front Biosci (Schol Ed) 2010, 2:1113-1126.
33. Lutz J., Thurmel K., Heemann U. Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation. J Inflamm (Lond) 2010, 7:27.
34. Ma A., Qi S., Chen H. Antioxidant therapy for prevention of inflammation, ischemic reperfusion injuries and allograft rejection. Cardiovasc Hematol Agents Med Chem 2008, 6:20-43.
35. Davidson-Moncada J., Papavasiliou F.N., Tam W. MicroRNAs of the immune system: roles in inflammation and cancer. Ann NY Acad Sci 2010, 1183:183-194.
36. Sotolongo B., Asaoka T., Island E., et al. Gene expression profiling of MicroRNAs in small-bowel transplantation paraffin-embedded mucosal biopsy tissue. Transplant Proc 2010, 42:62-65.
37. Mehra M.R., Uber P.A., Benitez R.M. Gene-based bio-signature patterns and cardiac allograft rejection. Heart Fail Clin 2010, 6:87-92.
38. Hartono C., Muthukumar T., Suthanthiran M. Noninvasive diagnosis of acute rejection of renal allografts. Curr Opin Organ Transplant 2010, 15:35-41.
39. Moynagh P.N. Toll-like receptor signalling pathways as key targets for mediating the anti-inflammatory and immunosuppressive effects of glucocorticoids. J Endocrinol 2003, 179:139-144.
40. O'Connell R.M., Taganov K.D., Boldin M.P., Cheng G., Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 2007, 104:1604-1609.
41. Lechler R., Ng W.F., Steinman R.M. Dendritic cells in transplantation-friend or foe?. Immunity 2001, 14:357-368.
42. Vigorito E., Perks K.L., Abreu-Goodger C., et al. MicroRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 2007, 27:847-859.
43. Tili E., Michaille J.J., Cimino A., et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007, 179:5082-5089.
44. Thai T.H., Calado D.P., Casola S., et al. Regulation of the germinal center response by microRNA-155. Science 2007, 316:604-608.
45. Teng G., Hakimpour P., Landgraf P., et al. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 2008, 28:621-629.
46. Haasch D., Chen Y.W., Reilly R.M., et al. T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. Cell Immunol 2002, 217:78-86.
47. Kim J.M., Rasmussen J.P., Rudensky A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 2007, 8:191-197.
48. Sun L., Yi S., O'Connell P.J. Foxp3 regulates human natural CD4+CD25+ regulatory T-cell-mediated suppression of xenogeneic response. Xenotransplantation 2010, 17:121-130.
49. Chott A.K., Pries R., Wollenberg B. Permanent up-regulation of regulatory T-lymphocytes in patients with head and neck cancer. Int J Mol Med 2010, 26:67-75.
50. Ozdemir C., Akdis M., Akdis C.A. T-cell response to allergens. Chem Immunol Allergy 2010, 95:22-44.
51. Cobb B.S., Hertweck A., Smith J., et al. A role for Dicer in immune regulation. J Exp Med 2006, 203:2519-2527.
52. Zheng Y., Josefowicz S.Z., Kas A., Chu T.T., Gavin M.A., Rudensky A.Y. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007, 445:936-940.
53. Marson A., Kretschmer K., Frampton G.M., et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 2007, 445:931-935.